Advertisement

Molecular Medicine

, Volume 19, Issue 1, pp 203–211 | Cite as

Carbenoxolone Blocks Endotoxin-Induced Protein Kinase R (PKR) Activation and High Mobility Group Box 1 (HMGB1) Release

  • Wei Li
  • Jianhua Li
  • Andrew E. Sama
  • Haichao Wang
Research Article

Abstract

The pathogen- and damage-associated molecular patterns (for example, bacterial endotoxin and adenosine 5′-triphosphate (ATP)) activate the double-stranded RNA-activated protein kinase R (PKR) to trigger the inflammasome-dependent high mobility group box 1 (HMGB1) release. Extracellular ATP contributes to the inflammasome activation through binding to the plasma membrane purinergic P2X7 receptor (P2X7R), triggering the opening of P2X7R channels and the pannexin-1 (panx-1) hemichannels permeable for larger molecules up to 900 daltons. It was previously unknown whether panx-1 channel blockers can abrogate lipopolysaccharide (LPS)-induced PKR activation and HMGB1 release in innate immune cells. Here we demonstrated that a major gancao (licorice) component (glycyrrhizin, or glycyrrhizic acid) derivative, carbenoxolone (CBX), dose dependently abrogated LPS-induced HMGB1 release in macrophage cultures with an estimated IC50 ≈ 5 µmol/L. In an animal model of polymicrobial sepsis (induced by cecal ligation and puncture (CLP)), repetitive CBX administration beginning 24 h after CLP led to a significant reduction of circulating and peritoneal HMGB1 levels, and promoted a significant increase in animal survival rates. As did P2X7R antagonists (for example, oxidized ATP, oATP), CBX also effectively attenuated LPS-induced P2X7R/panx-1 channel activation (as judged by Lucifer Yellow dye uptake) and PKR phosphorylation in primary peritoneal macrophages. Collectively, these results suggested that CBX blocks LPS-induced HMGB1 release possibly through impairing PKR activation, supporting the involvement of PKR in the regulation of HMGB1 release.

Notes

Acknowledgments

We thank Mala Ashok for assistance with animal experiments, Arvin Jundoria for critical reading of the manuscript, and Kevin J Tracey and Ben Lu for helpful discussions. This work was supported by the National Center of Complementary and Alternative Medicine (NCCAM, R01AT05076) and the National Institute of General Medical Sciences (NIGMS, R01GM063075).

References

  1. 1.
    Angus DC, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303–10.CrossRefGoogle Scholar
  2. 2.
    Ayala A, Song GY, Chung CS, Redmond KM, Chaudry IH. (2000) Immune depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin. Crit. Care Med. 28:2949–55.CrossRefPubMedGoogle Scholar
  3. 3.
    Xiang M, Fan J. (2010) Pattern recognition receptor-dependent mechanisms of acute lung injury. Mol. Med. 16:69–82.CrossRefPubMedGoogle Scholar
  4. 4.
    Chen GY, Tang J, Zheng P, Liu Y. (2009) CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science. 323:1722–5.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science. 272:735–8.CrossRefGoogle Scholar
  6. 6.
    Wang H, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:246–51.CrossRefGoogle Scholar
  7. 7.
    Lu B, et al. (2012) Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 488:670–4.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Yang H, et al. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A. 101:296–301.CrossRefGoogle Scholar
  9. 9.
    Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ. (2001) HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164:1766–73.CrossRefGoogle Scholar
  10. 10.
    Qin S, et al. (2006) Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp. Med 203:1637–42.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Wang H, Zhu S, Zhou R, Li W, Sama AE. (2008) Therapeutic potential of HMGB1-targeting agents in sepsis. Expert. Rev. Mol. Med 10:e32.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lamkanfi M, et al. (2010) Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J. Immunol. 185:4385–92.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Ali SR, et al. (2011) Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage. Immunity. 35:34–44.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Mehta VB, Hart J, Wewers MD. (2001) ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem. 276:3820–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Griffiths RJ, Stam EJ, Downs JT, Otterness IG. (1995) ATP induces the release of IL-1 from LPS-primed cells in vivo. J. Immunol. 154:2821–8.PubMedGoogle Scholar
  16. 16.
    Perregaux DG, McNiff P, Laliberte R, Conklyn M, Gabel CA. (2000) ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J. Immunol. 165:4615–23.CrossRefPubMedGoogle Scholar
  17. 17.
    Pelegrin P, Surprenant A. (2006) Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 25:5071–82.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Locovei S, Scemes E, Qiu F, Spray DC, Dahl G. (2007) Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett. 581:483–8.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Baroja-Mazo A, Barbera-Cremades M, Pelegrin P. (2013) The participation of plasma membrane hemichannels to purinergic signaling. Biochim. Biophys. Acta. 1828:79–93.CrossRefPubMedGoogle Scholar
  20. 20.
    Di Virgilio F. (2007) Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol. Sci. 28:465–72.CrossRefPubMedGoogle Scholar
  21. 21.
    Humphreys BD, Dubyak GR. (1996) Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. J. Immunol. 157:5627–37.PubMedGoogle Scholar
  22. 22.
    Ferrari D, Chiozzi P, Falzoni S, Hanau S, Di Virgilio F. (1997) Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185:579–82.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F. (1997) Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob. Agents Chemother. 41:551–6.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Okamoto T, Kanda T. (1999) Glycyrrhizin protects mice from concanavalin A-induced hepatitis without affecting cytokine expression. Int. J. Mol. Med. 4:149–52.PubMedGoogle Scholar
  25. 25.
    Yoshida T, et al. (2007) Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury. Eur. J. Pharmacol. 576:136–42.CrossRefPubMedGoogle Scholar
  26. 26.
    Menegazzi M, et al. (2008) Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice. Pharmacol. Res. 58:22–31.CrossRefPubMedGoogle Scholar
  27. 27.
    Liu Y, et al. (2011) Protective effects of glycyrrhizic acid by rectal treatment on a TNBS-induced rat colitis model. J. Pharm. Pharmacol. 63:439–46.CrossRefPubMedGoogle Scholar
  28. 28.
    Shearman DJ, Hetzel D. (1979) The medical management of peptic ulcer. Annu. Rev. Med. 30:61–79.CrossRefPubMedGoogle Scholar
  29. 29.
    Thompson RJ, Zhou N, MacVicar BA. (2006) Ischemia opens neuronal gap junction hemichannels. Science. 312:924–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Reigada D, Lu W, Zhang M, Mitchell CH. (2008) Elevated pressure triggers a physiological release of ATP from the retina: Possible role for pannexin hemichannels. Neuroscience. 157:396–404.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Sridharan M, et al. (2010) Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes. Am. J. Physiol Heart Circ. Physiol. 299: H1146–52.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Pelegrin P, Surprenant A. (2009) Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J. 28:2114–27.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Suzuki S, et al. (2004) Effects of carbenoxolone on alveolar fluid clearance and lung inflammation in the rat. Crit. Care Med. 32:1910–5.CrossRefPubMedGoogle Scholar
  34. 34.
    Tamura K, Alessandri B, Heimann A, Kempski O. (2011) The effect of a gap-junction blocker, carbenoxolone, on ischemic brain injury and cortical spreading depression. Neuroscience. 194:262–71.CrossRefPubMedGoogle Scholar
  35. 35.
    Li W, et al. (2007) A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1. PLoS ONE 2:e1153.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Zhang Y, et al. (2012) Tanshinone IIA sodium sulfonate facilitates endocytic HMGB1 uptake. Biochem. Pharmacol. 84:1492–500.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Li W, et al. (2011) A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation. PLoS ONE 6:e16945.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Li W, et al. (2011) EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochem. Pharmacol. 81:1152–63.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Chen G, et al. (2004) Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J. Leukoc. Biol. 76:994–1001.CrossRefPubMedGoogle Scholar
  40. 40.
    Li W, et al. (2007) A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. J. Immunol. 178:3856–64.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Rendon-Mitchell B, et al. (2003) IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J. Immunol. 170:3890–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Wang H, et al. (2006) The aqueous extract of a popular herbal nutrient supplement, Angelica sinensis, protects mice against lethal endotoxemia and sepsis. J. Nutr. 136:360–5.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Zhu S, et al. (2012) It is not just folklore: the aqueous extract of mung bean coat is protective against sepsis. Evid. Based. Complement Alternat. Med. 2012:498467.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Chen G, et al. (2004) Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J Leukoc. Biol 76:994–1001.CrossRefPubMedGoogle Scholar
  45. 45.
    Schachter J, et al. (2008) ATP-induced P2X7— associated uptake of large molecules involves distinct mechanisms for cations and anions in macrophages. J. Cell Sci. 121:3261–70.CrossRefPubMedGoogle Scholar
  46. 46.
    Cankurtaran-Sayar S, Sayar K, Ugur M. (2009) P2X7 receptor activates multiple selective dye-permeation pathways in RAW 264.7 and human embryonic kidney 293 cells. Mol. Pharmacol. 76:1323–32.CrossRefPubMedGoogle Scholar
  47. 47.
    Li W, et al. (2012) Use of animal model of sepsis to evaluate novel herbal therapies. J. Vis. Exp. (62):3926.Google Scholar
  48. 48.
    Zhu S, et al. (2009) Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol. Med 15:275–82.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Tang B, Qiao H, Meng F, Sun X. (2007) Glycyrrhizin attenuates endotoxin-induced acute liver injury after partial hepatectomy in rats. Braz. J. Med. Biol. Res. 40:1637–6.CrossRefPubMedGoogle Scholar
  50. 50.
    Davidson JS, Baumgarten IM, Harley EH. (1986) Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem. Biophys. Res. Commun. 134:29–36.CrossRefPubMedGoogle Scholar
  51. 51.
    Ma W, Hui H, Pelegrin P, Surprenant A. (2009) Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J. Pharmacol. Exp. Ther. 328:409–18.CrossRefPubMedGoogle Scholar
  52. 52.
    Poornima V, et al. (2012) P2X7 receptor-pannexin 1 hemichannel association: effect of extracellular calcium on membrane permeabilization. J. Mol. Neurosci. 46:585–94.CrossRefPubMedGoogle Scholar
  53. 53.
    Bujalska I, Shimojo M, Howie A, Stewart PM. (1997) Human 11 beta-hydroxysteroid dehydrogenase: studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue. Steroids. 62:77–82.CrossRefPubMedGoogle Scholar
  54. 54.
    Karatas H, et al. (2013) Spreading depression triggers headache by activating neuronal Panx1 channels. Science. 339:1092–5.CrossRefPubMedGoogle Scholar
  55. 55.
    Dahl G, Keane RW. (2012) Pannexin: from discovery to bedside in 11±4 years? Brain Res. 1487:150–9.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Author(s) 2013

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (https://doi.org/creativecommons.org/licenses/by-nc-nd/4.0/)

Authors and Affiliations

  • Wei Li
    • 1
    • 2
  • Jianhua Li
    • 1
  • Andrew E. Sama
    • 2
  • Haichao Wang
    • 1
    • 2
  1. 1.The Feinstein Institute for Medical ResearchManhassetUSA
  2. 2.Department of Emergency MedicineNorth Shore University HospitalManhassetUSA

Personalised recommendations